Validation Study of ClassIntra®

CompletedOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

July 6, 2018

Study Completion Date

August 31, 2018

Conditions
Patient SafetyIntraoperative ComplicationsPostoperative ComplicationsRisk Management
Interventions
OTHER

Observational study

No intervention, observational only

Trial Locations (18)

4031

University Hopsital Basel, Basel

28204

Carolinas Healthcare System, Charlotte

Unknown

Northern Sydney Colorectal Clinic, Sydney

Medical University of Innsbruck, Innsbruck

Barmherzige Brüder Krankenhaus, Vienna

Medical School, Aristotle University Thessaloniki, Thessaloniki

Trinity College Dublin at Tallaght, Dublin

National Cancer Institute, Naples

Radboud University Medical Centre, Nijmegen

Auckland City Hospital, Auckland

Hospital Valle de Hebron, Barcelona

University Childrens Hospital Basel, Basel

Kantonsspital Graubünden, Chur

University Hospital Lausanne, Lausanne

Bürgerspital Solothurn, Solothurn

Schulthess Clinique Zurich, Zurich

Ankara University Medical School, Ankara

Guy's and St. Thomas Hospital, London

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03009929 - Validation Study of ClassIntra® | Biotech Hunter | Biotech Hunter